Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Gross Margin (2016 - 2025)

Historic Gross Margin for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to 89.26%.

  • CorMedix's Gross Margin fell 47400.0% to 89.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 92.61%, marking a year-over-year increase of 86500.0%. This contributed to the annual value of 92.66% for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Gross Margin of 89.26% as of Q3 2025, which was down 47400.0% from 95.31% recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Gross Margin peaked at 8322.71% during Q1 2024, and registered a low of 76.12% during Q2 2021.
  • For the 4-year period, CorMedix's Gross Margin averaged around 612.59%, with its median value being 89.26% (2025).
  • Per our database at Business Quant, CorMedix's Gross Margin soared by 1745600bps in 2022 and then plummeted by -82268000bps in 2025.
  • CorMedix's Gross Margin (Quarter) stood at 14.88% in 2021, then soared by 563bps to 98.63% in 2022, then dropped by -2bps to 96.23% in 2024, then fell by -7bps to 89.26% in 2025.
  • Its last three reported values are 89.26% in Q3 2025, 95.31% for Q2 2025, and 95.91% during Q1 2025.